EGFRxCD16 bispecific antibodies orchestrate superior NK cell-mediated lysis of ovarian cancer and NSCLC cell lines in combination with oncolytic viruses.
Saved in:
| Title: | EGFRxCD16 bispecific antibodies orchestrate superior NK cell-mediated lysis of ovarian cancer and NSCLC cell lines in combination with oncolytic viruses. |
|---|---|
| Authors: | Gahbauer S; Department of Medicine Huddinge (MedH), Karolinska Institutet, Stockholm, Sweden., Poiret T; Department of Medicine Huddinge (MedH), Karolinska Institutet, Stockholm, Sweden. thomas.poiret@ki.se. |
| Source: | Cancer immunology, immunotherapy : CII [Cancer Immunol Immunother] 2026 Jul 03; Vol. 75 (7). Date of Electronic Publication: 2026 Jul 03. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Springer Verlag Country of Publication: Germany NLM ID: 8605732 Publication Model: Electronic Cited Medium: Internet ISSN: 1432-0851 (Electronic) Linking ISSN: 03407004 NLM ISO Abbreviation: Cancer Immunol Immunother Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1432-0851 |
|---|---|
| DOI: | 10.1007/s00262-026-04470-4 |
